Prudential Financial Inc. Increases Stock Holdings in Phibro Animal Health Co. (NASDAQ:PAHC)

Prudential Financial Inc. lifted its stake in shares of Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) by 405.8% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 120,655 shares of the company's stock after acquiring an additional 96,800 shares during the period. Prudential Financial Inc. owned 0.30% of Phibro Animal Health worth $2,534,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently modified their holdings of PAHC. Hussman Strategic Advisors Inc. acquired a new stake in Phibro Animal Health during the fourth quarter worth $2,205,000. Jacobs Levy Equity Management Inc. raised its holdings in Phibro Animal Health by 116.6% in the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 192,255 shares of the company's stock valued at $4,330,000 after buying an additional 103,491 shares during the period. American Century Companies Inc. lifted its position in Phibro Animal Health by 18.0% in the fourth quarter. American Century Companies Inc. now owns 635,599 shares of the company's stock valued at $13,348,000 after buying an additional 96,787 shares during the last quarter. Raymond James Financial Inc. purchased a new position in Phibro Animal Health during the fourth quarter worth about $1,103,000. Finally, Wakefield Asset Management LLLP acquired a new stake in shares of Phibro Animal Health during the fourth quarter valued at about $1,020,000. Institutional investors and hedge funds own 99.34% of the company's stock.

Analysts Set New Price Targets

A number of analysts have issued reports on PAHC shares. StockNews.com lowered Phibro Animal Health from a "buy" rating to a "hold" rating in a research report on Tuesday, March 25th. Morgan Stanley boosted their price objective on Phibro Animal Health from $20.00 to $25.00 and gave the company an "equal weight" rating in a report on Tuesday, December 17th. Finally, Barclays raised their target price on Phibro Animal Health from $20.00 to $22.00 and gave the company an "underweight" rating in a report on Monday, February 10th. Two analysts have rated the stock with a sell rating and three have given a hold rating to the stock. According to MarketBeat.com, Phibro Animal Health currently has an average rating of "Hold" and a consensus price target of $21.00.

Remove Ads

Phibro Animal Health Stock Down 4.2 %

Shares of NASDAQ PAHC traded down $0.78 during mid-day trading on Tuesday, hitting $17.88. The company had a trading volume of 197,411 shares, compared to its average volume of 187,547. The company has a market capitalization of $724.19 million, a PE ratio of 37.25, a price-to-earnings-growth ratio of 0.45 and a beta of 0.63. The business's 50-day simple moving average is $22.48 and its 200 day simple moving average is $22.56. Phibro Animal Health Co. has a 1-year low of $12.30 and a 1-year high of $26.55. The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.37.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. On average, analysts predict that Phibro Animal Health Co. will post 1.95 earnings per share for the current year.

Phibro Animal Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Wednesday, March 5th were paid a dividend of $0.12 per share. The ex-dividend date of this dividend was Wednesday, March 5th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.68%. Phibro Animal Health's payout ratio is currently 100.00%.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.